ITRM vs SNPS · rev $390.0K vs P/E 63, rev $7.05B
Iterum Therapeutics PLC (ITRM) versus Synopsys Inc (SNPS) — a side-by-side from cached financials, not a winner call.
Iterum Therapeutics PLC (ITRM) is a biotechnology company listed on US.
Synopsys Inc (SNPS) is a software - infrastructure company listed on US.
Latest reported ITRM revenue for 2025-09-30 was $390.0K. Net income was -$20.4M. ITRM currently screens at market cap $38.6M.
Latest reported SNPS revenue for 2025-10-31 was $7.05B. Net income was $1.33B. Revenue was up 15.1% from 2024-10-31 to 2025-10-31. SNPS currently screens at market cap $85.14B and trailing P/E 63.3.
ITRM currently screens at market cap $38.6M. SNPS currently screens at market cap $85.14B and trailing P/E 63.3.
Not investment advice. Open the ITRM and SNPS stock pages for the full models.
Not investment advice.